Tuberculosis (TB) causes a heavy health burden worldwide, especially in developing countries. The need for the rapid and accurate diagnosis of TB has not been satisfied, especially for extra-pulmonary specimens or specimens with acid fast stain (AFS)-negative condition. Development and validation of a novel, sensitive and specific assay for diagnosing TB is essential. We developed IS4 primer/ probe based on insertion sequence 6110 (IS6110). A qPCR assay was designed for detecting a specific region in IS6110 by BLAST. The IS4 primer/probe concentration, qPCR efficiency and various of PCR additives were evaluated and optimized. Thirty-four species of commonly isolated microorganisms were used for evaluating the analytical specificity. Moreover, 130 clinical specimens were collected for evaluating the performance versus Cobas TaqMan We concluded that IS4, a new primer/probe pair for TaqMan based qPCR assay, was developed, optimized, and validated for the sensitive and specific detection of TB among various specimen types. The performance was not compromised under AFS-negative conditions. Tuberculosis (TB) infects approximately 10.4 million people and causes 1.4 million deaths annually 1 . TB is one of the top ten causes of death in low-income (6 th place) and lower-middle-income (5 th place) countries according
to an epidemiological report from the World Health Organization (WHO) 1 . It was reported that over 95% of TB-caused deaths occur in low-and middle-income countries. The correct and early diagnosis of TB could elicit the initiation of anti-TB treatments and infection control. It was estimated that 53 million deaths were prevented due to correct anti-TB treatments between 2000 and 2016 1 . Improvements in TB diagnosis and standardized anti-TB treatments are the keys to the WHO's End-TB strategy 2, 3 . Correct treatments against TB mainly depend on accurate TB diagnosis 4 . Various diagnostic methods, including acid fast stain (AFS), TB culture, nucleic acid hybridization probes, line probe assays, and nucleic acid amplification tests (NAATs), have been developed for TB diagnosis [4] [5] [6] . AFS provides the technical advantage of low cost, fast turn-around-time (TAT), and simple implementation. However, this method was reported to have low sensitivity and specificity for TB diagnosis 5 . TB culture is regarded as the gold standard method for TB diagnosis 4, 6, 7 . In clinical practice, TB culture is normally performed as a back-up test method for AFS 4, 5, 7 . TB culture is generally believed to be accurate, but the TAT largely depends on the growth rate of TB bacteria, which is regarded as slow-growing mycobacterium. Consequently, the time required for TB diagnosis could be longer than weeks to months, which hinders rapid diagnosis and TB treatment. In contrast, both nucleic acid hybridization probes and line probe assays use oligonucleotide probes to identify differences in target 16S or 23S rDNA for discriminating TB from other non-tuberculosis Mycobacterium (NTM) 5 . These methods have been reported to be accurate and even able to detect rifampicin or isoniazid drug resistance 4 . These methods do not rely on nucleic acid amplification to provide a sufficient number of target molecules for the tests 5 . To address the above mentioned issues, NAATs were developed for improvement in TAT for TB diagnosis. NAAT methods can achieve superior performance over TB culture-based methods. Several DNA regions, including the intergenic spacer (ITS) from the 16S or 23S rRNA genes, MPB64, insertion sequences 986 or 6110 (IS986 or IS6110), etc., have been selected as NAAT PCR targets 8 . Insertion sequences (ISs) are the smallest and most numerous independently transposable mobile genetic elements widely present in shaping their host genomes, such as eukaryotic and bacterial genomes [9] [10] [11] . IS elements carry genes encoding a transposase in their host sequence, which increases their host opportunity to survive in a variety environmental conditions. Genome diversification, deletions, inversions, duplications and other host arrangements have been due to IS mobilization and expansion via transposition 12, 13 . Mycobacterium tuberculosis contains at least 30 different IS elements in its genome, one of which, IS6110, is present in MTB complex (MTBC) members in multiple copies (over 25 copies), except in Mycobacterium bovis BCG, in which it appears to be present as a single or fewer copies, and other mycobacteria, where it is absent 14 . Consequently, it has been reported that IS6110 could be widely used for TB diagnosis in clinical specimens; previous studies have established the validity of the detection rate and sensitivity of MTBC targeting IS6110, showing that it was significantly higher than culturing MTB for a long time period [15] [16] [17] [18] . Both commercial and laboratory developed test (LDT) NAATs have been developed based on these target regions. The Roche Cobas TaqMan MTB (CTM) assay which focuses on a segment of the 16S rRNA gene 19 is one of the most widely used commercial NAATs and it has attained 96% sensitivity and 74% specificity with AFS-positive smears, while the sensitivity and specificity dropped to 64% and 99.3%, respectively, with AFS-negative smears 5, 20 . The result indicated CTM assay is good for AFS-positive cases; however, the sensitivity is suboptimal for AFS-negative cases, which is especially difficult for rapid diagnosis and treatment. Besides, despite the fact that manufacturer instruction narrowed CTM application only for the pulmonary specimens, some researchers also evaluated the diagnostic accuracy of CTM for the extrapulmonary specimens. A meta-analysis study analyzing 15 studies indicated that the diagnostic accuracy of CTM for the pulmonary specimens was superior to the extrapulmonary specimens. The summary indicated sensitivity and specificity is 81% and 99% in the pulmonary specimens, while the sensitivity and specificity dropped to 59% and 98%, respectively, for the extrapulmonary specimens 19 . In addition to CTM, the Xpert MTB/RIF assay (Cepheid, Sunnyvale, CA) is another commercialized NAATs, which approved by World Health Organization for rapid TB diagnosis, allows completely automated nuclei acids preparation, amplification, and detection rifampin resistance of M. tuberculosis by quantitative PCR with a disposable single test cartridge in the meantime. One study indicated it has attained 100% sensitivity and 67% specificity with AFS-positives cases; whereas those values were 40% and 99%, respectively with AFS-negative cases 21 . Another study also reported that the sensitivity of Xpert MTB/RIF was much higher for AFS-positive disease (99.0%) compared with AFS-negative disease (70.3%) 21 . Moreover, the sensitivity and specificity of Xpert were 79.0% and 97%, respectively in the extrapulmonary specimens when TB culture serves as the reference method 21 . In brief, sensitivity of Xpert MTB/RIF test for extrapulmonary samples was found to be at moderate level; sensitivity of the test was found to be decreased especially in AFS-negative samples. In summary, CTM and Xpert MTB/RIF have consistently shown high sensitivity among AFS-and culture-positive specimens, however their variable sensitivity in AFS-negative or extrapulmonary specimens has raised concern 22, 23 . The added benefit of NAATs over AFS could be limited owing to the insufficient sensitivity for AFS-negative cases. Moreover, commercial assays cannot fulfil the needs for testing MTBC in extrapulmonary specimens, which may account for considerable numbers of samples in tertiary teaching hospitals. The cost may be another issue, as the cost would be higher for a commercially available kit than for LDT NAATs, given that most TB-prevalent areas are developing countries 5, 6 . Consequently, re-addressing the issue of MTBC NAATs and developing an efficient LDT NAAT is essential.
In this study, we designed a novel quantitative real-time polymerase chain reaction (qPCR)-based NAAT based on IS6110. IS6110 is a MTBC NAAT target region 8 . The discriminating advantage of IS6110 over other targets is that IS6110 was almost only identified in MTBC 24, 25 . The proposed method was optimized and evaluated with respect to its analytical sensitivity and specificity. Moreover, 130 clinical specimens were collected for method validation. The CTM assay and the proposed method were conducted simultaneously with AFS and culture to evaluate performance. 
Results
Establishing the primer/probe sets for the multiplex qPCR assay. We developed a new multiplex TaqMan-based qPCR assay to determine MTBC. In addition to designing specific primer/probe sets for MTBC detection, we also designed primer/probe sets for Lambda plasmid DNA, which were used as an internal control in our assay. Three amplicon colours were determined by differences in the peak emission wavelength of the three fluorescent dyes, including 6-FAM-labelled IS4 probe emitting blue, HEX-labelled Lambda DNA probe emitting green, and ROX, a passive reference dye, emitting red. Our main goals for designing primers were a GC content of 50-60%, an optimal melting temperature for the primers ranging from 60-62 °C and a primer length was shorter than 25 bases. The probes are in the middle of the forward and reverse primer binding sites, did not overlap with the primer-binding site on the sense strand and have a Tm 10 °C higher than the primer.
A highly conserved region inside IS6110 was chosen for detecting MTBC. IS6110 is an insertion sequence that is found exclusively within the MTBC that comprises M. tuberculosis, M. africanum, M. bovis, M. cannetti, M. caprae, M. microti, and M. pinnipedi. This element has been recognized as a multi-copy target for the molecular detection of MTBC, which increases the detection sensitivity; this has been mentioned by many reports. In our study, we also chose IS6110 as our target region for designing the specific primers and probe due to its highly conserved DNA sequence between MTBC. As expected, the IS6110 DNA sequence shares 99.9% identity with MTBC. The partial IS6110 nucleotide sequences from MTBC are shown in Fig. 1 . Two single nucleotide polymorphisms occur in M. cannetti and M. microti. The IS4 amplicon and probe binding site are inside the red box (Fig. 1) . The results also confirmed that IS6110 has become an important diagnostic tool in the differentiation of MTBC species from other mycobacteria because it shows a highly conserved sequence. We could not find the M. pinnipedi IS6110 sequence in the NCBI database, so the data is not shown.
Validation of the qPCR assay with international standards. To verify the efficiency of real-time PCR amplification, the primer and probe set sensitivity were investigated. The synthetic IS6110 plasmid DNA, which included the IS4 primer/probe set target region, was obtained at a concentration of 10 8 genomic DNA copies. The synthetic IS6110 plasmid DNA was serially diluted 10-fold to 10 2 genomic DNA copies and were used to construct a standard curve. coefficient (R 2 -value) > 0.99 for the singleplex PCR standard curve (without the Lambda DNA primer/probe sets) ( Fig. 2(a) ). In contrast, for the multiplex PCR standard curve (with the Lambda DNA primer/probe sets), the IS4 primer efficiency (E) was 102.4%, with a slope of −3.26, and showed a similar correlation coefficient to the IS4 singleplex reaction. The results may indicate that the Lambda DNA primer/probe sets may slightly disturb the IS4 primer/probe. Compared with the IS4 singleplex reaction (Ct values from 13.9 to 33.2), the multiplex results produced amplification curves with relatively higher Ct values (15.8 to 35.6), suggesting a lower sensitivity by the multiplex reaction ( Fig. 2(b) ). Given that the Lambda DNA primer/probe sets may disturb the IS4 primer efficiency, we spiked a relatively lower Lambda DNA copy (1,000 copies) and decreased the primer/probe concentration. The Ct values under these conditions were approximately 30 ( Fig. 2(c) ). Briefly, the Lambda DNA primer/probe sets may elicit interference from the IS4 primer/probe sets, but the effect was minor. The efficiency of the IS4 primer/probe sets was high and was also specific for its target region (no other non-specific bands were observed in the agarose gel electrophoresis) (Supplemental Fig. 1 ).
Dimethyl sulfoxide (DMSO) improves qPCR sensitivity. We evaluated various additives (bovine serum albumin (BSA), Glycerol and DMSO) to optimize the analytical sensitivity of the qPCR reaction.
Comparison of the glycerol, BSA and no additives, 4% DMSO produced a relatively low Ct value (35.2 ± 0.28) ( Fig. 3(a) ). A significant difference in the Ct values among the various additives was noted (P = 0.0013). The negative rate was lowest (8.3%) when DMSO served as the additive compared with the other additives ( Fig. 3(b) ). The theoretical limit of detection (LOD) is lower than 10. Ten copies of standard plasmid were used to determine the LOD of the assay. The LOD was confirmed by repeating the qPCR twenty-one times. qPCR with DMSO as additive revealed a positive rate higher than 90%, while the other treatments attained lower positive rates (58% for BSA, 83% for glycerol, and 75% for no additive). The limit of detection (LOD) of the test was estimated to be lower than 10 copies (Fig. 3(b) ).
The best concentration of forward versus reverse primer is two-fold. We determined the Ct value of different primer concentration combinations to optimize the qPCR conditions. The results indicated that the Ct value was lowest when the forward and reverse primer concentrations were 700 nM and 350 nM, respectively, when the DNA template was 100, 1,000 and 10,000 copies ( Fig. 4(a-c) , respectively).
Analytical specificity. Various commonly isolated microorganisms were used for evaluating the analytical specificity. Eleven clinically occurring non-tuberculosis mycobacterium (NTM), seven bacterial species and sixteen fungal species that are commonly reported as causes of respiratory infections clinically were used as quality control samples. All the strains were obtained from the microbiology laboratory at the Chang Gung Memorial Hospital (CGMH) at Linkou (Supplemental Table 1 Supplemental Table 2 ), indicating a low rate of cross-reactivity. The degree of agreement (kappa as the index) versus the CTM was 0.71 (95% confidence interval from 0.58-0.83), indicating good agreement. The overall clinical sensitivity and specificity were 92.11% (35/38) and 82.61% (76/92) with respect to culture as the gold standard, respectively (Table 1 , panel: overall specimens). The performance of the IS4 assay versus the CTM qPCR kit and culture was also compared under various specimen conditions. In pulmonary specimens, namely, sputum and bronchoalveolar larvage (BAL) specimens, IS4 showed 10 positive results from 41 cases that were revealed to be negative by the CTM assay. Similarly, the IS4 assay showed 9 positive results from 39 culture negative cases. The clinical sensitivity and specificity were 92.00% (23/25) and 76.92% (30/39) for the pulmonary specimens with respect to culture as the gold standard, respectively (Table 1 , panel: on pulmonary specimens). In the extrapulmonary specimens, the IS4 assay showed 6 positive results from 53 cases that were not detected by the CTM assay, while the IS4 assay showed 7 positive results from 53 culture negative cases. The clinical sensitivity and specificity were 92.31% (12/13) and 86.79% (46/53) for the extrapulmonary specimens with respect to culture as the gold standard, respectively (Table 1 , panel: on extrapulmonary specimens). When AFS showed a positive result, the IS4 qPCR assay showed 1 positive among 4 CTM negative cases ( Table 2 ). Among the negative AFS cases, the IS4 qPCR assay showed 15 positive results from 90 cases called negative by the CTM, while the IS4 qPCR assay showed 14 positive results from the 87 negative culture cases. Under the conditions when AFS was negative, the degree of agreement (kappa as the index) versus the CTM was 0.63 (95% confidence interval from 0.46-0.79), which also indicated good agreement. The clinical sensitivity and specificity were 90.48% (19/21) and 83.91% (73/87) with respect to culture as the gold standard, respectively (Table 1 , panel: on AFS-negative specimens). Moreover, we summarized the sensitivity and specificity of IS4 and CTM with 95% confidence intervals under various conditions (Table 2) . 
Discussion
New diagnostic tools are key in the successful fight against TB globally 3 . NAATs are recommended by the WHO as initial tools for cases suspected to have TB. The CDC from the USA also suggested that a NAAT be performed on at least one respiratory specimen with suspected TB 6 . An IS6110-based qPCR assay for diagnosing TB was developed in this study. The concentrations of the PCR primers and additives were tested to attain optimal sensitivity. Moreover, clinical specimens were collected for the validation of the qPCR index. The results showed that the index test revealed higher clinical sensitivity than the CTM assay. The index test also showed high performance in both pulmonary and extrapulmonary specimens. Additionally, the index test displayed a high sensitivity when analysing AFS-negative specimens. We developed and validated a high sensitivity qPCR test that may be useful for diagnosing TB in various types of specimens.
IS6110 is one of the most common regions selected as a PCR target for diagnosing TB 8 . The exclusivity of IS6110 in MTBC provides a discriminative diagnostic tool for differentiating TB from NTM or other bacteria 26 . However, some NTM strains have been reported to contain specific DNA fragments that are homologous to IS6110 27 . Some studies have also shown that IS6110 primer pairs cross-react with M. peregrinum and M. chelonae 28 . The cross-reactivity of previously published primers and probes with environmental mycobacteria is common. Consequently, it is necessary to develop a new set of primers and probes for greater detection specificity. To address this issue, we selected the IS6110 C-terminal region, which has not been chosen by previous reports, as our target. We first blasted the IS4 sequence for different organism categories, including 62 kinds of bacteria, 12 kinds of fungi, and 14 kinds of viruses, according to reference genomic DNA sequence in the NCBI database (data not shown). We also examined the primer specificity by using DNAs from multiple common bacterial, NTM, and fungal species (Supplemental Table 1 ). Moreover, IS4 showed high specificity in the clinical performance evaluation ( Table 1 ). All of the dry or wet lab results demonstrated that IS4 showed highly specific amplification for detecting MTBC. The frequency of NTM isolation from clinical specimens has significantly increased in several countries 4, 29, 30 . The symptoms and signs between TB infection and some NTM infection are not always easy to distinguish. Moreover, some important NTMs (e.g., M. kansasii) shared similar slow growth rates with TB, which has led to early diagnosis difficulty. AFS can rapidly identify the presence of mycobacteria in clinical specimens. However, AFS displays low sensitivity and cannot distinguish TB from NTM. As a rapid diagnostic tool, IS4 was designed with this issue in mind. The ability of IS4 to distinguish TB from NTM would be an advantageous and essential characteristic in patient management and infection control (Supplemental Tables 1 and 2) .
Early diagnosis depends on culture-independent methods, such as AFS and qPCR. The early administration of an anti-TB agent could be initiated once AFS shows a positive result. AFS is a rapid and inexpensive test method; however, it has poor sensitivity. Many true TB infections are not initially detected by AFS. Consequently, the true value of a qPCR assay over other test methods may lie in AFS-negative cases 4, 8, 31 . qPCR could also provide the added value of detecting paucibacillary disease. Diagnosing paucibacillary disease is essential for clinically diagnosed TB cases that are highly suspected to be infected with TB but all the lab tests fail to provide bacteriological evidence 4 . Equivocal TB cases are considerably frequent in clinical practice because of inappropriate diagnostic methods 6 . Clinically diagnosed TB cases could be troublesome to both physicians and patients owing to the lack of confidence in the administration of anti-TB drugs and isolation policies. The clinical validation study revealed that the IS4 assay was more sensitive than the CTM assay or culture in AFS-negative cases (Table 1 , panel: overall specimens). For AFS-negative cases, the IS4 assay detected 14 positives from 87 cases that were not detected by culture. We conducted a medical chart review for these 14 cases ( Table 2 ). The IS4 assay may provide valuable hints to both physicians and patients when TB is highly suspected and there is no evidence from traditional test methods. The medical chart review results implied that the IS4 assay could detect minimal bacterial loads in latent TB cases. The high detection sensitivity may provide additional information for physicians in deciding the initiation of anti-TB treatments. In contrast, for AFS-positive specimens, the advantages of the IS4 assay over AFS are its ability to distinguish MTBC from NTMs 4, 32, 33 . Several commercial TB diagnostic tools are doing well and widely applied in many countries. However, current commercial TB diagnostic tool, CTM and GeneXpert, are approved for pulmonary specimens and not for extrapulmonary specimens. TB can infect various tissue types beside lung tissues. In this investigation, the IS4 assay showed similar performance in both pulmonary and extrapulmonary specimens ( Table 1 , panel: on pulmonary and extrapulmonary specimens). In CGMH, TB qPCR requests obtained from extrapulmonary specimens have already accounted for half of all the TB qPCR orders. Additional validation on both pulmonary and extrapulmonary specimens is necessary for both commercial and in-house developed TB qPCR assays. Moreover, GeneXpert TB diagnostic tools can detect TB and drug resistance simultaneously by multiplexing qPCR 34 . This design can enhance the TAT of TB detection and anti-TB resistance detection, which is especially useful in high TB and high drug resistance prevalence settings. In contrast, the positive predictive value of anti-TB drug resistance would be low in a low prevalence setting 4 . The additional cost and time of a test to confirm anti-TB drug resistance adversely suggests the use of a multiplex test in low a TB burden setting. In Taiwan, the resistance rate of new TB cases to rifampicin is 2% 35 . The IS4 qPCR conditions were optimized by the addition of additives. BSA, glycerol, and DMSO were used and evaluated in this study. All three additives are common materials for enhancing PCR performance. BSA has been reported to enhance the PCR process by stabilizing DNA polymerase 36 . Glycerol is an enzyme-stabilizing solvent and enhances PCR yield through a similar mechanism as BSA 37 . Moreover, DMSO reduces the Tm and the complex secondary structure so that qPCR sensitivity can be enhanced [38] [39] [40] . The effects of BSA, glycerol, and DMSO on qPCR efficiency were evaluated and are shown in Fig. 3(a) , where PCR with DMSO as an additive showed lower Ct than the other additives. No difference was observed between BSA and glycerol. Moreover, DMSO also outperformed the other additives when studying the LOD (Fig. 3(b) ), where the qPCR reaction with DMSO could attain the most stable results (the representative rate is 91.7%) when the initial amount of nucleic acid was very low (e.g., 10 copies in the LOD study). The results implied that the improvement in the qPCR efficacy and the LOD in the IS4 assay may be due to the reduction in the Tm or nucleic acid secondary structures. The possible interactions between primers, probes, and the target template could also be observed in the primer optimization study (Fig. 4) . The F700-R700 pair did not attain the lowest Ct value. In contrast, slightly reduced reverse primer (R350) with F700 resulted in the most effective application with lower initial DNA amounts (i.e., 100 copies). The phenomenon could result from the location of the IS4 probe. The IS4 probe is located on the sense strand and close to the forward primer. The location of the IS4 probe may therefore have an effect on the forward primer binding site. The interaction between primers and the target template may also be the reason hindering the optimal yield. DMSO, therefore, is a reasonable additive for reducing these interactions. There are some limitations in this study that may hinder its wide application in the current setting. First, the IS4 qPCR method was validated at a single tertiary medical centre. The clinical performance of the IS4 qPCR assay should be re-validated in other hospitals, especially those with different epidemiological settings. Second, we only focused on developing new qPCR primers and a probe pair. Specimen pre-processing and DNA purification prior to qPCR analysis should be evaluated on several other instruments that expose a higher risk of cross-contamination 5 . Further work on the development of a closed PCR system (i.e., from-specimen-to-result system) is necessary in the future. Moreover, as a qPCR method, IS4 cannot distinguish live from non-viable MTBC and cannot be used to monitor responses to treatment. AFS, culture, and clinical data are still essential for a more comprehensive diagnosis of TB infection. qPCR additive evaluation. PCR additives have been used to enhance the signal and increase the yield, specificity and consistency of PCR reactions. These additives may have different effects on PCR amplification under particular conditions. We chose three different functional additives, including DMSO, BSA and glycerol, in our study. Given that GC content of IS6110 is 62%, DMSO was chosen for this GC-rich template, which may promote DNA double strand dissociation, reduce the secondary structures of the IS4 primer/probe sets, and prevent primer/target mis-priming.
Materials and Methods

Mycobacterium
Real-Time PCR Analysis. Each multiplex PCR assay was performed in a 30 µl final reaction volume containing 15 µl of 2X QuantiNova Probe PCR mastermix (Qiagen, Hilden, Germany), 1.5 µl ROX passive reference dye (an inert additive that provides a constant fluorescent signal for sample normalization, which was provided by Applied Biosystems), 0.2 μl of 100 pmol/μl IS4F (forward primer for the target region), 0.2 μl of 50 pmol/μl IS4R (reverse primer for the target region), 0.8 μl of 1pmol/μl IS4P (probe for the target region), 9 µl of DNA (10 8 -10 2 genome copies), 1.2 µl of 100% DMSO (Alfa Aesar 36480AP), 0.4 µl of 10 pmol/μl LdF (forward primer for Lambda) and LdR primers (reverse primer for Lambda), 0.2 μl of 10 pmol/μl LdP (probe for Lambda), 1 μl of Lambda DNA (as spiked DNA, 1,000 genome copies) and 0.1 μl of nuclease-free water.
The following thermal profile was used with the Applied Biosystems StepOne real-time PCR system (Applied Biosystems, Carlsbad, CA): (1) an initial step of 2 min at 95 °C and (2) 40 cycles of 5 s at 95 °C and 10 s at 60 °C. A negative control with double-distilled water was performed for each real-time PCR experiment.
Primer and probe design. All of the probes and primers were synthesized by Integrated DNA Technologies, Inc. (http://www.idtdna.com). The primer and probe design was based on the homology region of the partial insertion sequence 6110 (IS6110) in the Mycobacterium tuberculosis complex (MTBc) for all species. A 141 base pair region, which represents one of the most highly conserved regions, was chosen as the target region for primer amplification. The sense and antisense primers and double quenched probe were designated IS4F, IS4R, and IS4P, respectively. The fluorogenic IS4P probe labelled with a unique fluorescent reporter dye ] at the 5′-end, an internal ZEN Quencher and a 3′-Iowa Black Fluorescent Quencher (IBFQ), was designed to anneal to an internal sequence in the amplified region. A 48 kb-Lambda DNA plasmid (Genbank) isolated from bacteriophage lambda (cI857ind 1 Sam 7) was chosen as an internal control to check the qPCR process. The sense and antisense primers used to amplify the Lambda DNA were manually designed to amplify a 111 bp amplicon inside the 34,000-35,000 region, which has no conserved sequence in the BL21(DE3) E. coli strain and were designated LdF and LdR, respectively. The probe was covalently labelled with 4,4,7,2′,4′,5′,7′-hexachloro-6 -carboxyfluorescein (HEX) at the 5′-end, an internal ZEN Quencher and a 3′-Iowa Black Fluorescent Quencher (IBFQ) at the 3′-end and was designated LdP. The primer was designed using the online PrimerQuest Tool on IDT website (https://sg.idtdna.com/PrimerQuest/Home/ Index). All the primers, probes used for real-time PCR have listed in Table 3 .
Clinical specimens. The Specimen processing. AFS and culture for the detection of mycobacteria were ordered together for each specimen. For sputum and pus specimens, N-acetyl-L-cysteine and NaOH were mixed with specimens for mucolysis and decontamination, respectively. The mixture was incubated for 15 minutes after adequate mixing. After incubation, the mixture was centrifuged with 3420 g at 20 °C for 15 minutes. The supernatant was discarded and the sediment was collected for the smear (1 cm × 2 cm). Phosphate buffer was added to neutralize the remaining sediment for culture. In contrast, for fluid specimens (i.e., BAL, CSF, pleural effusion, and ascites), the specimen was centrifuged under 3420 g at 20 °C for 15 minutes. The supernatant was discarded and phosphate buffer was added to neutralize the remaining sediment. For tissue specimens, the specimen was cut into small pieces, followed by the addition of 1 ml 0.9% saline. The supernatant was taken for the smear and culture. The clinical specimens in suspicious of TB were processed in biosafety level (BSL)-3 area.
Acid Fast Stain. The processed specimens were spread on a slide for the smear (1 cm × 2 cm). A smear was completely covered by 0.3% Ziehl-Neelsen carbofuchsin (Wako Pure Chemical Industries Ltd., Osaka, Japan), followed by adequate heating for 5 seconds. The smear was incubated at room temperature for 5 minutes. The smear was then rinsed with sterile water (ddH 2 O) followed by 3% acid alcohol. Subsequently, the smear was rinsed again with sterile water (ddH 2 O), followed by the addition of 0.3% methylene blue onto the smear for 25 seconds. The AFS test was performed in BSL-3 area.
Mycobacteria culture. We performed cultures in both solid and liquid media. The processed specimen was dropped onto Lowenstein Jensen (LJ) Media (Creative Life Sciences Inc., New Taipei City, Taiwan) and the LJ media was incubated at 36 °C and 5% CO 2 . A small volume (0.5 ml) of the processed specimen was added into Mycobacteria Growth Indicator Tubes (MGIT) and incubated with the BD BACTEC ™ MGIT ™ system (Becton Dickinson, MD, USA). A subculture was created in 7H11 media (Creative Life Sciences, New Taipei City, Taiwan), followed by positive growth in MGIT. A single colony obtained from either LJ media or 7H11 media was collected for species identification. We performed preliminary species identification of mycobacteria based on the growth rate and colony texture. An immunochromatographic test (TAUNS Laboratories Inc., Shizuoka, Japan) was used for confirming the MTBC. For the isolates whose growth rates and colony textures did not suggest MTBC, a MicroFlex LT mass spectrometer (Bruker Daltonik GmbH, Leipzig, Germany) was used to identify the NTM species. We observed the growth status of both LJ media and MGIT for 8 weeks. Negative mycobacterium growth was reported when no growth was noted within 8 weeks. The TB culture was performed in BSL-3 area.
Nucleic acid extraction. DNA was extracted from the specimens before nucleic acid amplification for either the proposed qPCR method (i.e., IS4) or the reference qPCR. For sputum and pus specimens, 300 μl of the specimen were mixed with 330 μl lysis buffer and 30 proteinase K, followed by incubation at 56 °C for 10 minutes for inactivation. For tissue specimens, the specimen was cut into small pieces and then 1 ml 0.9% saline was added, followed by incubation at 56 °C for 10 minutes. All the specimens were processed in BSL-3 area until inactivation. The nucleic acid extraction and PCR assay were performed in BSL-2 condition. The nucleic acids were isolated from 300 μl of the inactivated mixture and the DNA was extracted into 60 μl elution buffer using a LabTurbo nucleic acids Extraction Kit (TaiGen Biotechnology Inc., Taiwan) according to the manufacturer's specifications. Statistical analysis. Analysis of variance (ANOVA) was used to determine the Ct values between the treatments with the various PCR additives. We used Tukey's honest significant difference post hoc test for further comparison when the null hypothesis of ANOVA was rejected. Graph Pad Prism 5.0. was used for the statistical analysis and a p value < 0.05 was considered statistically significant. The 95% confidence intervals of sensitivity and specificity of IS4 and CTM were estimated by the method proposed by Agresti and Coull 41 .
Reference qPCR (CTM assay).
